Heteroaryl substituted pyrolls useful as inhibitors of protein kinases

Details for Australian Patent Application No. 2004212421 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Maltais, Francois; Hale, Michael R.; Tang, Qing; Aronov, Alex

Agent Cullen & Co

Pub. Number AU-B-2004212421

PCT Pub. Number WO2004/072063

Priority 60/445,962 07.02.03 US; 60/463,847 18.04.03 US

Filing date 3 February 2004

Wipo publication date 26 August 2004

Acceptance publication date 20 August 2009

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

C08K 5/34 (2006.01) Use of organic ingredients

C08K 5/48 (2006.01) Use of organic ingredients

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/072063 Priority application(s): WO2004/072063

20 August 2009 Application Accepted

  Published as AU-B-2004212421

17 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004212435-Process for preparing pyrrolotriazine kinase inhibitors

2004212402-Crystal of intermediate for carbapenem